Mankind Pharma Limited (NSE:MANKIND)
2,463.00
-74.80 (-2.95%)
Aug 8, 2025, 3:30 PM IST
Mankind Pharma Revenue
Mankind Pharma had revenue of 35.70B INR in the quarter ending June 30, 2025, with 23.40% growth. This brings the company's revenue in the last twelve months to 129.10B, up 21.22% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.
Revenue (ttm)
129.10B
Revenue Growth
+21.22%
P/S Ratio
8.11
Revenue / Employee
4.79M
Employees
26,978
Market Cap
1,047.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 122.07B | 19.47B | 18.98% |
Mar 31, 2024 | 102.60B | 15.11B | 17.27% |
Mar 31, 2023 | 87.49B | 9.68B | 12.44% |
Mar 31, 2022 | 77.82B | 15.67B | 25.22% |
Mar 31, 2021 | 62.14B | 3.43B | 5.83% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 77.86B |
Aurobindo Pharma | 320.25B |
Alkem Laboratories | 129.65B |